These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37478012)

  • 1. Kynurenine monooxygenase regulates inflammation during critical illness and recovery in experimental acute pancreatitis.
    Hayes AJ; Zheng X; O'Kelly J; Neyton LPA; Bochkina NA; Uings I; Liddle J; Baillie JK; Just G; Binnie M; Homer NZM; Murray TBJ; Baily J; McGuire K; Skouras C; Garden OJ; Webster SP; Iredale JP; Howie SEM; Mole DJ
    Cell Rep; 2023 Aug; 42(8):112763. PubMed ID: 37478012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.
    Mole DJ; Webster SP; Uings I; Zheng X; Binnie M; Wilson K; Hutchinson JP; Mirguet O; Walker A; Beaufils B; Ancellin N; Trottet L; Bénéton V; Mowat CG; Wilkinson M; Rowland P; Haslam C; McBride A; Homer NZ; Baily JE; Sharp MG; Garden OJ; Hughes J; Howie SE; Holmes DS; Liddle J; Iredale JP
    Nat Med; 2016 Feb; 22(2):202-9. PubMed ID: 26752518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
    Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
    J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback.
    Wilson K; Auer M; Binnie M; Zheng X; Pham NT; Iredale JP; Webster SP; Mole DJ
    Cell Death Dis; 2016 Apr; 7(4):e2197. PubMed ID: 27077813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury.
    Zheng X; Zhang A; Binnie M; McGuire K; Webster SP; Hughes J; Howie SEM; Mole DJ
    Exp Mol Med; 2019 Feb; 51(2):1-14. PubMed ID: 30760699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
    Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
    Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
    Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
    J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.
    Parrott JM; Redus L; Santana-Coelho D; Morales J; Gao X; O'Connor JC
    Transl Psychiatry; 2016 Oct; 6(10):e918. PubMed ID: 27754481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxykynurenine Regulates Lipopolysaccharide-Stimulated IL-6 Production and Protects against Endotoxic Shock in Mice.
    Hoshi M; Kubo H; Ando T; Tashita C; Nakamoto K; Yamamoto Y; Tezuka H; Saito K
    Immunohorizons; 2021 Jun; 5(6):523-534. PubMed ID: 34183381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of 3-hydroxykynurenine parallel disease severity in human acute pancreatitis.
    Skouras C; Zheng X; Binnie M; Homer NZ; Murray TB; Robertson D; Briody L; Paterson F; Spence H; Derr L; Hayes AJ; Tsoumanis A; Lyster D; Parks RW; Garden OJ; Iredale JP; Uings IJ; Liddle J; Wright WL; Dukes G; Webster SP; Mole DJ
    Sci Rep; 2016 Sep; 6():33951. PubMed ID: 27669975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.
    Erhardt S; Pocivavsek A; Repici M; Liu XC; Imbeault S; Maddison DC; Thomas MAR; Smalley JL; Larsson MK; Muchowski PJ; Giorgini F; Schwarcz R
    Biol Psychiatry; 2017 Nov; 82(10):756-765. PubMed ID: 28187857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease.
    Bondulich MK; Fan Y; Song Y; Giorgini F; Bates GP
    Sci Rep; 2021 Mar; 11(1):5484. PubMed ID: 33750843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification.
    Wilson K; Mole DJ; Binnie M; Homer NZ; Zheng X; Yard BA; Iredale JP; Auer M; Webster SP
    Protein Expr Purif; 2014 Mar; 95(100):96-103. PubMed ID: 24316190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia.
    Tufvesson-Alm M; Schwieler L; Schwarcz R; Goiny M; Erhardt S; Engberg G
    Neuropharmacology; 2018 Aug; 138():130-139. PubMed ID: 29879409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas.
    Vázquez Cervantes GI; Pineda B; Ramírez Ortega D; Salazar A; González Esquivel DF; Rembao D; Zavala Vega S; Gómez-Manzo S; Pérez de la Cruz G; Pérez de la Cruz V
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel causative role of imbalanced kynurenine pathway in ulcerative colitis: Upregulation of KMO and KYNU promotes intestinal inflammation.
    Shi Y; Luo S; Zhai J; Chen Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166929. PubMed ID: 37918679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO).
    Winkler D; Beconi M; Toledo-Sherman LM; Prime M; Ebneth A; Dominguez C; Muñoz-Sanjuan I
    J Biomol Screen; 2013 Sep; 18(8):879-89. PubMed ID: 23690293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid.
    Mori Y; Mouri A; Kunisawa K; Hirakawa M; Kubota H; Kosuge A; Niijima M; Hasegawa M; Kurahashi H; Murakami R; Hoshi M; Nakano T; Fujigaki S; Fujigaki H; Yamamoto Y; Nabeshima T; Saito K
    Behav Brain Res; 2021 May; 405():113191. PubMed ID: 33607168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.